Neuroimaging studies have shown several neurophysiological substrates for depression: An overview by Theodore Henderson, MD, PhD.
Byproduct of ketamine metabolism underlies the antidepressant-like activity of the agent in mice.
China's U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.
Ketamine and other drugs targeting the brain's NMDA receptors may benefit treatment-resistant depression.
Psychiatry Advisor Articles
- Cognitive Alterations in a Growing Population of Cancer Survivors
- Addressing Common Nutritional Deficiencies in Autism
- Physical Activity During Midlife Influences Late Life Verbal Memory Performance
- Children With ADHD May Adapt More Poorly To Changes In Positive Reinforcement Patterns
- Functional Role of Adult-Born Neurons in Stress Vulnerability and Resilience
- Electroconvulsive Therapy Continues to Be Vital Depression Treatment in Elderly
- Psilocybin May Provide Swift Relief From Depression, Anxiety in Cancer Patients
- Clinical Hypnosis May Be Effective for Cancer Pain, IBS, Headaches
- Methylphenidate & CBT Benefits TBI Patients with Cognitive Problems
- Expert Opinion on the Surgeon General's Report on Addiction